http://medicalxpress.com/news/2013-0...us-cancer.html
Genetically engineered virus shown to help kill Liver Cancer in a phase II study.
Quote:
Sixteen patients given a high dose of the therapy survived for 14.1 months on average, compared to 6.7 months for the 14 who got the low dose.
|